Free Trial

Kellanova (K) Financials

Kellanova logo
$82.45 +0.16 (+0.19%)
As of 03:58 PM Eastern
Annual Income Statements for Kellanova

Annual Income Statements for Kellanova

This table shows Kellanova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
614 699 1,254 1,336 960 1,251 1,481 958 951 1,330
Consolidated Net Income / (Loss)
614 700 1,254 1,344 977 1,264 1,488 960 964 1,343
Net Income / (Loss) Continuing Operations
614 700 1,254 1,148 977 1,264 1,103 731 788 1,356
Total Pre-Tax Income
773 934 1,657 1,329 1,305 1,601 1,452 902 1,040 1,654
Total Operating Income
1,091 1,483 1,387 1,706 1,401 1,761 1,383 1,211 1,505 1,873
Total Gross Profit
4,681 4,834 4,699 4,726 4,381 4,727 3,818 3,811 4,283 4,545
Total Revenue
13,525 12,965 12,854 13,547 13,578 13,770 11,747 12,653 13,122 12,749
Operating Revenue
13,525 12,965 12,854 13,547 13,578 13,770 11,747 12,653 13,122 12,749
Total Cost of Revenue
8,844 8,131 8,155 8,821 9,197 9,043 7,929 8,842 8,839 8,204
Operating Cost of Revenue
8,844 8,131 8,155 8,821 9,197 9,043 7,929 8,842 8,839 8,204
Total Operating Expenses
3,590 3,351 3,312 3,020 2,980 2,966 2,435 2,600 2,778 2,672
Selling, General & Admin Expense
3,590 3,351 3,312 3,020 2,980 2,966 2,435 2,600 2,778 2,672
Total Other Income / (Expense), net
-318 -549 270 -377 -96 -160 72 -300 -465 -213
Interest Expense
227 406 256 287 284 281 205 201 303 311
Interest & Investment Income
- - - - - - 3.00 9.00 - 6.00
Other Income / (Expense), net
-91 -143 526 -90 188 121 274 -108 -162 92
Income Tax Expense
159 235 410 181 321 323 353 180 258 304
Net Income / (Loss) Discontinued Operations
- - - - - - 392 231 176 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 1.00 0.00 8.00 17 13 7.00 2.00 13 13
Basic Earnings per Share
$1.74 $1.99 $3.61 $3.85 $2.81 $3.65 $8.72 $5.62 $2.78 $7.84
Weighted Average Basic Shares Outstanding
354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Diluted Earnings per Share
$1.72 $1.97 $3.58 $3.83 $2.80 $3.63 $8.66 $5.58 $2.76 $7.76
Weighted Average Diluted Shares Outstanding
354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Weighted Average Basic & Diluted Shares Outstanding
354M 350M 347.40M 347M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Cash Dividends to Common per Share
$1.98 $2.04 $2.12 $2.20 $2.26 $2.28 $2.31 $2.34 $2.34 $2.26

Quarterly Income Statements for Kellanova

This table shows Kellanova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
310 -100 298 352 268 33 267 341 364 358
Consolidated Net Income / (Loss)
312 -102 302 357 269 36 271 344 367 361
Net Income / (Loss) Continuing Operations
312 -331 234 298 198 58 271 347 370 368
Total Pre-Tax Income
383 -437 293 372 277 98 353 443 402 456
Total Operating Income
368 -89 346 417 414 328 393 493 456 531
Total Gross Profit
1,153 356 984 1,094 1,110 1,095 1,031 1,161 1,176 1,177
Total Revenue
3,946 1,171 3,342 3,351 3,255 3,174 3,200 3,192 3,233 3,124
Operating Revenue
3,946 1,171 3,342 3,351 3,255 3,174 3,200 3,192 3,233 3,124
Total Cost of Revenue
2,793 815 2,358 2,257 2,145 2,079 2,169 2,031 2,057 1,947
Operating Cost of Revenue
2,793 815 2,358 2,257 2,145 2,079 2,169 2,031 2,057 1,947
Total Operating Expenses
785 445 638 677 696 767 638 668 720 646
Selling, General & Admin Expense
785 445 638 677 696 767 638 668 720 646
Total Other Income / (Expense), net
15 -339 -53 -42 -138 -232 -40 -49 -52 -72
Interest Expense
39 52 70 73 75 85 83 83 75 70
Other Income / (Expense), net
54 -296 17 28 -62 -145 43 33 21 -5.00
Income Tax Expense
74 -103 61 77 78 42 82 97 34 91
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 -2.00 4.00 5.00 1.00 3.00 4.00 3.00 3.00 3.00
Basic Earnings per Share
$0.91 $2.51 $0.87 $2.08 $1.58 ($1.75) $0.78 $2.02 $2.14 $2.90
Weighted Average Basic Shares Outstanding
341M 341.83M 342M 343M 342M 340.68M 341M 342M 343M 345.22M
Diluted Earnings per Share
$0.90 $2.50 $0.86 $2.06 $1.56 ($1.72) $0.78 $2.00 $2.10 $2.88
Weighted Average Diluted Shares Outstanding
344M 341.83M 345M 345M 345M 340.68M 344M 345M 347M 345.22M
Weighted Average Basic & Diluted Shares Outstanding
341.28M 341.83M 342.76M 342.35M 342.52M 340.68M 341.88M 342.29M 344.70M 345.22M
Cash Dividends to Common per Share
$0.59 $0.59 $0.59 $0.59 $0.60 $0.56 $0.56 $0.56 $0.57 $0.57

Annual Cash Flow Statements for Kellanova

This table details how cash moves in and out of Kellanova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-192 29 1.00 40 76 38 -149 13 -25 420
Net Cash From Operating Activities
1,691 1,271 403 1,536 1,176 1,986 1,701 1,651 1,645 1,760
Net Cash From Continuing Operating Activities
1,675 1,107 403 1,536 1,176 1,986 1,701 1,651 1,645 1,760
Net Income / (Loss) Continuing Operations
614 700 1,254 1,344 977 1,264 1,495 962 964 1,356
Consolidated Net Income / (Loss)
614 700 1,254 1,344 977 1,264 1,495 962 964 1,356
Depreciation Expense
534 517 481 516 484 479 467 478 419 367
Non-Cash Adjustments To Reconcile Net Income
457 217 -234 -321 -220 -54 -388 271 259 194
Changes in Operating Assets and Liabilities, net
70 -327 -1,098 -3.00 -65 297 127 -60 3.00 -157
Net Cash From Investing Activities
-1,127 -392 149 -948 774 -585 -528 -448 -562 -750
Net Cash From Continuing Investing Activities
-1,127 -392 149 -948 774 -585 -528 -448 -562 -750
Purchase of Property, Plant & Equipment
-553 -507 -501 -578 -586 -505 -553 -488 -677 -628
Acquisitions
-617 -400 -592 -417 0.00 0.00 -10 0.00 0.00 0.00
Purchase of Investments
0.00 -2.00 -7.00 -8.00 -18 -331 -61 -17 53 -357
Divestitures
- 27 0.00 0.00 1,332 0.00 0.00 0.00 0.00 0.00
Sale and/or Maturity of Investments
- - 0.00 0.00 83 269 91 56 64 209
Other Investing Activities, net
43 490 1,249 55 -37 -18 5.00 1.00 -2.00 26
Net Cash From Financing Activities
-706 -786 -604 -566 -1,905 -1,388 -1,306 -1,081 -1,110 -607
Net Cash From Continuing Financing Activities
-706 -786 -604 -566 -1,905 -1,388 -1,306 -1,081 -1,110 -607
Repayment of Debt
-889 -4,630 -870 -706 -1,104 -1,303 -748 -665 -1,224 -663
Repurchase of Common Equity
-731 -426 -516 -320 -220 0.00 -240 -300 -170 0.00
Payment of Dividends
-700 -716 -736 -762 -769 -782 -788 -797 -800 -776
Issuance of Debt
1,353 4,618 1,421 1,055 124 585 407 404 1,102 619
Issuance of Common Equity
261 368 97 167 64 112 63 277 60 213
Other Financing Activities, net
- - - 0.00 0.00 0.00 0.00 0.00 -78 0.00
Effect of Exchange Rate Changes
-50 -64 53 18 31 - -16 -109 2.00 17
Cash Interest Paid
228 405 258 280 284 249 213 220 291 303
Cash Income Taxes Paid
337 256 352 188 537 281 365 312 322 244

Quarterly Cash Flow Statements for Kellanova

This table details how cash moves in and out of Kellanova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
50 -74 48 -39 791 -825 -32 30 297 125
Net Cash From Operating Activities
375 471 276 368 756 245 364 376 553 467
Net Cash From Continuing Operating Activities
375 471 276 368 756 245 364 376 553 467
Net Income / (Loss) Continuing Operations
312 -100 302 362 270 30 271 347 370 368
Consolidated Net Income / (Loss)
312 -100 302 362 270 30 271 347 370 368
Depreciation Expense
113 127 116 110 112 81 86 95 92 94
Non-Cash Adjustments To Reconcile Net Income
-60 437 -8.00 -2.00 76 193 252 -16 -3.00 -39
Changes in Operating Assets and Liabilities, net
10 7.00 -134 -102 298 -59 -245 -50 94 44
Net Cash From Investing Activities
6.00 -136 -205 -139 -128 -90 -333 -121 -135 -161
Net Cash From Continuing Investing Activities
6.00 -136 -205 -139 -128 -90 -333 -121 -135 -161
Purchase of Property, Plant & Equipment
-83 -138 -203 -136 -167 -171 -155 -142 -143 -188
Purchase of Investments
-5.00 -39 12 -4.00 6.00 39 -182 -2.00 -124 -49
Sale and/or Maturity of Investments
5.00 42 5.00 5.00 5.00 49 0.00 13 132 64
Other Investing Activities, net
89 -1.00 -19 -4.00 28 -7.00 4.00 10 - 12
Net Cash From Financing Activities
-282 -416 -33 -266 179 -990 -58 -232 -127 -190
Net Cash From Continuing Financing Activities
-282 -416 -33 -266 179 -990 -58 -232 -127 -190
Repayment of Debt
-151 -652 -251 -30 -1.00 -942 110 -681 -75 -17
Payment of Dividends
-202 -201 -202 -202 -206 -190 -191 -192 -197 -196
Issuance of Common Equity
71 33 19 26 6.00 9.00 23 22 145 23
Effect of Exchange Rate Changes
-49 7.00 10 -2.00 -16 10 -5.00 7.00 6.00 9.00

Annual Balance Sheets for Kellanova

This table presents Kellanova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
15,251 15,111 16,351 17,780 17,564 17,996 18,178 18,496 15,621 15,628
Total Current Assets
3,236 2,940 3,036 3,157 3,431 3,482 3,394 4,186 3,330 3,754
Cash & Equivalents
251 280 281 321 397 435 286 299 274 694
Accounts Receivable
1,344 1,231 1,389 1,375 1,576 1,537 1,489 1,532 1,568 1,522
Inventories, net
1,250 1,238 1,217 1,330 1,226 1,284 1,398 1,339 1,243 1,165
Other Current Assets
391 191 149 131 232 226 221 378 245 373
Plant, Property, & Equipment, net
3,621 3,569 3,716 3,731 3,612 3,713 3,827 3,090 3,212 3,234
Total Noncurrent Assets
8,394 8,602 9,599 10,892 10,521 10,801 10,957 11,220 9,079 8,640
Long-Term Investments
456 438 429 413 404 391 424 432 184 99
Goodwill
4,968 5,166 5,504 6,050 5,861 5,799 5,771 5,381 5,160 5,003
Intangible Assets
2,268 2,369 2,639 3,361 2,576 2,491 2,409 2,239 1,930 1,760
Other Noncurrent Operating Assets
702 629 1,027 1,068 1,680 2,120 2,353 1,890 1,805 1,778
Total Liabilities & Shareholders' Equity
15,251 15,111 16,351 17,780 17,564 17,996 18,178 18,496 15,621 15,628
Total Liabilities
13,113 13,185 14,157 14,621 14,250 14,360 13,963 14,121 12,252 11,746
Total Current Liabilities
5,739 4,474 4,522 4,529 4,778 5,238 5,315 6,349 5,060 4,660
Short-Term Debt
2,470 1,069 779 686 727 729 849 1,247 784 745
Accounts Payable
1,907 2,014 2,269 2,427 2,387 2,471 2,573 2,568 2,314 2,236
Accrued Expenses
- - - - 641 1,154 1,014 1,027 1,044 870
Other Current Liabilities
1,362 1,391 1,474 1,416 1,023 884 879 959 918 809
Total Noncurrent Liabilities
7,374 8,711 9,635 10,092 9,472 9,122 8,648 7,772 7,192 7,086
Long-Term Debt
5,275 6,698 7,836 8,207 7,195 6,746 6,262 5,317 5,089 4,998
Noncurrent Deferred & Payable Income Tax Liabilities
685 525 355 730 596 562 722 707 497 541
Noncurrent Employee Benefit Liabilities
946 1,024 839 651 705 769 706 593 613 599
Other Noncurrent Operating Liabilities
468 464 605 504 976 1,045 958 972 993 948
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,138 1,926 2,194 3,159 3,314 3,636 4,215 4,375 3,369 3,882
Total Preferred & Common Equity
2,128 1,910 2,178 2,601 2,747 3,112 3,720 3,941 3,175 3,775
Total Common Equity
2,128 1,910 2,178 2,601 2,747 3,112 3,720 3,941 3,175 3,775
Common Stock
850 911 983 1,000 1,026 1,077 1,128 1,173 1,206 1,226
Retained Earnings
6,597 6,571 7,069 7,652 7,859 8,326 9,028 9,197 8,804 9,358
Treasury Stock
-3,943 -3,997 -4,417 -4,551 -4,690 -4,559 -4,715 -4,721 -4,794 -4,533
Accumulated Other Comprehensive Income / (Loss)
-1,376 -1,575 -1,457 -1,500 -1,448 -1,732 -1,721 -1,708 -2,041 -2,276
Noncontrolling Interest
10 16 16 558 567 524 495 434 194 107

Quarterly Balance Sheets for Kellanova

This table presents Kellanova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
19,016 18,496 18,630 18,101 18,695 15,621 15,315 15,299 15,763 15,628
Total Current Assets
4,444 4,186 4,324 4,288 4,986 3,330 3,450 3,470 3,855 3,754
Cash & Equivalents
373 299 347 308 1,099 274 242 272 569 694
Accounts Receivable
1,985 1,532 1,820 1,930 1,876 1,568 1,666 1,654 1,699 1,522
Inventories, net
1,682 1,339 1,801 1,706 1,632 1,243 1,210 1,185 1,219 1,165
Other Current Assets
404 378 356 344 379 245 332 359 368 373
Plant, Property, & Equipment, net
3,564 3,090 3,786 3,781 3,762 3,212 3,101 3,118 3,218 3,234
Total Noncurrent Assets
11,008 11,220 10,520 10,032 9,947 9,079 8,764 8,711 8,690 8,640
Long-Term Investments
427 432 434 323 194 184 100 107 101 99
Goodwill
5,691 5,381 5,690 5,517 5,496 5,160 5,067 5,043 5,045 5,003
Intangible Assets
2,302 2,239 2,297 2,091 2,065 1,930 1,828 1,804 1,799 1,760
Other Noncurrent Operating Assets
2,588 1,890 2,099 2,101 2,192 1,805 1,769 1,757 1,745 1,778
Total Liabilities & Shareholders' Equity
19,016 18,496 18,630 18,101 18,695 15,621 15,315 15,299 15,763 15,628
Total Liabilities
14,278 14,121 14,151 13,880 14,418 12,252 12,037 11,872 12,005 11,746
Total Current Liabilities
6,033 6,349 6,001 6,476 6,524 5,060 5,525 4,774 4,975 4,660
Short-Term Debt
990 1,247 1,038 1,660 1,546 784 1,539 856 802 745
Accounts Payable
2,871 2,568 2,900 2,810 2,789 2,314 2,209 2,267 2,368 2,236
Accrued Expenses
1,130 1,027 1,027 1,093 1,191 1,044 945 899 937 870
Other Current Liabilities
1,042 959 1,036 913 998 918 832 752 868 809
Total Noncurrent Liabilities
8,245 7,772 8,150 7,404 7,894 7,192 6,512 7,098 7,030 7,086
Long-Term Debt
5,697 5,317 5,759 5,078 5,530 5,089 4,395 5,007 5,051 4,998
Noncurrent Deferred & Payable Income Tax Liabilities
923 707 728 659 702 497 513 526 437 541
Noncurrent Employee Benefit Liabilities
603 593 711 712 722 613 596 580 554 599
Other Noncurrent Operating Liabilities
1,022 972 952 955 940 993 1,008 985 988 948
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,738 4,375 4,479 4,221 4,277 3,369 3,278 3,427 3,758 3,882
Total Preferred & Common Equity
4,283 3,941 4,052 3,965 4,038 3,175 3,152 3,307 3,650 3,775
Total Common Equity
4,283 3,941 4,052 3,965 4,038 3,175 3,152 3,307 3,650 3,775
Common Stock
1,132 1,173 1,138 1,161 1,175 1,206 1,168 1,187 1,210 1,226
Retained Earnings
9,499 9,197 9,293 9,447 9,509 8,804 8,878 9,027 9,195 9,358
Treasury Stock
-4,750 -4,721 -4,666 -4,700 -4,692 -4,794 -4,723 -4,699 -4,557 -4,533
Accumulated Other Comprehensive Income / (Loss)
-1,598 -1,708 -1,713 -1,943 -1,954 -2,041 -2,171 -2,208 -2,198 -2,276
Noncontrolling Interest
455 434 427 256 239 194 126 120 108 107

Annual Metrics and Ratios for Kellanova

This table displays calculated financial ratios and metrics derived from Kellanova's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-7.24% -4.14% -0.86% 5.39% 0.23% 1.41% -14.69% 7.71% 3.71% -2.84%
EBITDA Growth
-0.20% 21.06% 28.92% -10.94% -2.77% 13.89% -10.04% -25.57% 11.45% 32.35%
EBIT Growth
-3.29% 34.00% 42.76% -15.53% -1.67% 18.44% -11.96% -33.43% 21.76% 46.31%
NOPAT Growth
9.26% 28.07% -5.95% 41.18% -28.32% 33.07% -25.53% -7.40% 16.74% 35.09%
Net Income Growth
-3.00% 14.01% 79.14% 7.18% -27.31% 29.38% 17.72% -35.48% 0.42% 39.32%
EPS Growth
-1.71% 14.53% 81.73% 6.98% -26.89% 29.64% 138.57% -35.57% -50.54% 181.16%
Operating Cash Flow Growth
-5.69% -24.84% -68.29% 281.14% -23.44% 68.88% -14.35% -2.94% -0.36% 6.99%
Free Cash Flow Firm Growth
-33.45% -10.68% -106.12% 417.56% 661.57% -19.78% -53.99% 257.98% -46.51% 8.03%
Invested Capital Growth
-6.15% -2.19% 12.52% 12.07% -7.80% -1.44% 3.22% -15.01% -2.65% 0.55%
Revenue Q/Q Growth
-2.68% -0.72% 1.08% 0.98% -0.69% 1.78% -17.42% 1.48% 18.01% -0.39%
EBITDA Q/Q Growth
34.44% 5.75% 30.96% -23.45% 17.99% 2.34% -11.61% -22.46% 42.10% 18.02%
EBIT Q/Q Growth
59.74% 7.03% 46.93% -29.62% 26.61% 2.95% -14.28% -29.61% 73.29% 21.15%
NOPAT Q/Q Growth
35.81% 6.67% 18.03% 2.04% -0.82% 4.40% -23.95% -2.61% 33.99% 13.97%
Net Income Q/Q Growth
70.08% -0.99% 58.73% -27.08% 31.49% 4.64% 17.26% -35.53% 16.71% 31.93%
EPS Q/Q Growth
65.38% 0.00% 59.11% -27.32% 30.84% 4.91% 136.61% -35.64% -60.46% 145.57%
Operating Cash Flow Q/Q Growth
6.69% -27.08% -8.41% 34.86% -23.39% 7.70% 10.60% -4.90% -12.08% 14.43%
Free Cash Flow Firm Q/Q Growth
2.12% -18.35% -110.74% 127.66% -24.48% 3.13% -14.74% 144.20% -2.76% -39.82%
Invested Capital Q/Q Growth
-7.02% -3.54% 6.96% -4.14% 1.27% 1.41% -0.59% -15.08% -12.68% -1.22%
Profitability Metrics
- - - - - - - - - -
Gross Margin
34.61% 37.29% 36.56% 34.89% 32.27% 34.33% 32.50% 30.12% 32.64% 35.65%
EBITDA Margin
11.34% 14.32% 18.62% 15.74% 15.27% 17.15% 18.08% 12.50% 13.43% 18.29%
Operating Margin
8.07% 11.44% 10.79% 12.59% 10.32% 12.79% 11.77% 9.57% 11.47% 14.69%
EBIT Margin
7.39% 10.34% 14.88% 11.93% 11.70% 13.67% 14.11% 8.72% 10.23% 15.41%
Profit (Net Income) Margin
4.54% 5.40% 9.76% 9.92% 7.20% 9.18% 12.67% 7.59% 7.35% 10.53%
Tax Burden Percent
79.43% 74.95% 75.68% 101.13% 74.87% 78.95% 102.48% 106.43% 92.69% 81.20%
Interest Burden Percent
77.30% 69.70% 86.62% 82.24% 82.13% 85.07% 87.63% 81.78% 77.44% 84.17%
Effective Tax Rate
20.57% 25.16% 24.74% 13.62% 24.60% 20.17% 24.31% 19.96% 24.81% 18.38%
Return on Invested Capital (ROIC)
9.14% 12.23% 10.94% 13.76% 9.71% 13.57% 10.02% 9.87% 12.71% 17.36%
ROIC Less NNEP Spread (ROIC-NNEP)
5.53% 6.41% 13.76% 12.15% 8.67% 11.51% 16.78% 9.70% 9.38% 13.77%
Return on Net Nonoperating Assets (RNNOA)
15.47% 22.22% 49.93% 36.45% 20.47% 22.81% 27.89% 12.48% 12.19% 19.69%
Return on Equity (ROE)
24.61% 34.45% 60.87% 50.21% 30.19% 36.37% 37.91% 22.35% 24.90% 37.04%
Cash Return on Invested Capital (CROIC)
15.49% 14.44% -0.84% 2.38% 17.83% 15.02% 6.85% 26.09% 15.39% 16.81%
Operating Return on Assets (OROA)
6.58% 8.83% 12.16% 9.47% 8.99% 10.58% 9.16% 6.02% 7.87% 12.58%
Return on Assets (ROA)
4.04% 4.61% 7.97% 7.88% 5.53% 7.11% 8.23% 5.24% 5.65% 8.60%
Return on Common Equity (ROCE)
24.26% 34.23% 60.40% 44.83% 24.94% 30.66% 32.99% 19.93% 22.88% 35.51%
Return on Equity Simple (ROE_SIMPLE)
28.85% 36.65% 57.58% 51.67% 35.57% 40.62% 40.00% 24.36% 30.36% 35.58%
Net Operating Profit after Tax (NOPAT)
867 1,110 1,044 1,474 1,056 1,406 1,047 969 1,132 1,529
NOPAT Margin
6.41% 8.56% 8.12% 10.88% 7.78% 10.21% 8.91% 7.66% 8.62% 11.99%
Net Nonoperating Expense Percent (NNEP)
3.62% 5.82% -2.81% 1.61% 1.04% 2.06% -6.76% 0.17% 3.33% 3.58%
Return On Investment Capital (ROIC_SIMPLE)
8.77% 11.45% 9.66% 12.23% 9.40% 12.65% 9.24% 8.86% 12.24% 15.88%
Cost of Revenue to Revenue
65.39% 62.72% 63.44% 65.11% 67.73% 65.67% 67.50% 69.88% 67.36% 64.35%
SG&A Expenses to Revenue
26.54% 25.85% 25.77% 22.29% 21.95% 21.54% 20.73% 20.55% 21.17% 20.96%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.54% 25.85% 25.77% 22.29% 21.95% 21.54% 20.73% 20.55% 21.17% 20.96%
Earnings before Interest and Taxes (EBIT)
1,000 1,340 1,913 1,616 1,589 1,882 1,657 1,103 1,343 1,965
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,534 1,857 2,394 2,132 2,073 2,361 2,124 1,581 1,762 2,332
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
8.29 9.58 7.86 5.76 6.73 5.58 4.97 5.37 5.79 7.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.30 1.41 1.33 1.11 1.36 1.26 1.58 1.67 1.40 2.18
Price to Earnings (P/E)
28.72 26.17 13.65 11.21 19.24 13.87 12.49 22.10 19.34 20.89
Dividend Yield
3.98% 3.91% 4.28% 5.10% 4.17% 4.52% 4.26% 3.77% 4.36% 2.80%
Earnings Yield
3.48% 3.82% 7.32% 8.92% 5.20% 7.21% 8.00% 4.53% 5.17% 4.79%
Enterprise Value to Invested Capital (EV/IC)
2.69 2.83 2.48 2.09 2.51 2.38 2.39 3.04 2.73 3.72
Enterprise Value to Revenue (EV/Rev)
1.82 1.96 1.95 1.75 1.93 1.78 2.16 2.17 1.83 2.58
Enterprise Value to EBITDA (EV/EBITDA)
16.09 13.65 10.46 11.11 12.62 10.39 11.96 17.35 13.62 14.08
Enterprise Value to EBIT (EV/EBIT)
24.68 18.92 13.09 14.66 16.46 13.03 15.33 24.87 17.87 16.71
Enterprise Value to NOPAT (EV/NOPAT)
28.48 22.85 23.99 16.07 24.77 17.45 24.26 28.30 21.21 21.48
Enterprise Value to Operating Cash Flow (EV/OCF)
14.60 19.95 62.14 15.42 22.25 12.35 14.93 16.62 14.59 18.66
Enterprise Value to Free Cash Flow (EV/FCFF)
16.82 19.34 0.00 93.02 13.49 15.77 35.48 10.71 17.51 22.18
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
3.62 4.03 3.93 2.82 2.39 2.06 1.69 1.50 1.74 1.48
Long-Term Debt to Equity
2.47 3.48 3.57 2.60 2.17 1.86 1.49 1.22 1.51 1.29
Financial Leverage
2.80 3.47 3.63 3.00 2.36 1.98 1.66 1.29 1.30 1.43
Leverage Ratio
6.09 7.47 7.64 6.38 5.46 5.12 4.61 4.27 4.41 4.31
Compound Leverage Factor
4.71 5.21 6.61 5.24 4.48 4.35 4.04 3.49 3.41 3.63
Debt to Total Capital
78.37% 80.13% 79.70% 73.79% 70.51% 67.28% 62.78% 60.01% 63.55% 59.67%
Short-Term Debt to Total Capital
24.99% 11.03% 7.21% 5.69% 6.47% 6.56% 7.50% 11.40% 8.48% 7.74%
Long-Term Debt to Total Capital
53.37% 69.10% 72.50% 68.10% 64.04% 60.71% 55.29% 48.61% 55.06% 51.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.10% 0.17% 0.15% 4.63% 5.05% 4.72% 4.37% 3.97% 2.10% 1.11%
Common Equity to Total Capital
21.53% 19.70% 20.15% 21.58% 24.45% 28.01% 32.84% 36.03% 34.35% 39.22%
Debt to EBITDA
5.05 4.18 3.60 4.17 3.82 3.17 3.35 4.15 3.33 2.46
Net Debt to EBITDA
4.59 3.80 3.30 3.83 3.44 2.82 3.01 3.69 3.07 2.12
Long-Term Debt to EBITDA
3.44 3.61 3.27 3.85 3.47 2.86 2.95 3.36 2.89 2.14
Debt to NOPAT
8.94 7.00 8.25 6.03 7.50 5.32 6.79 6.77 5.19 3.76
Net Debt to NOPAT
8.12 6.35 7.57 5.54 6.74 4.73 6.12 6.02 4.79 3.24
Long-Term Debt to NOPAT
6.09 6.04 7.51 5.57 6.81 4.80 5.98 5.49 4.50 3.27
Altman Z-Score
2.32 2.47 2.39 2.19 2.38 2.37 2.31 2.34 2.68 3.42
Noncontrolling Interest Sharing Ratio
1.44% 0.64% 0.78% 10.72% 17.38% 15.70% 12.98% 10.81% 8.11% 4.15%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.56 0.66 0.67 0.70 0.72 0.66 0.64 0.66 0.66 0.81
Quick Ratio
0.28 0.34 0.37 0.37 0.41 0.38 0.33 0.29 0.36 0.48
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,468 1,311 -80 255 1,939 1,556 716 2,562 1,371 1,481
Operating Cash Flow to CapEx
305.79% 250.69% 80.44% 265.74% 200.68% 393.27% 307.59% 338.32% 242.98% 280.25%
Free Cash Flow to Firm to Interest Expense
6.47 3.23 -0.31 0.89 6.83 5.54 3.49 12.75 4.52 4.76
Operating Cash Flow to Interest Expense
7.45 3.13 1.57 5.35 4.14 7.07 8.30 8.21 5.43 5.66
Operating Cash Flow Less CapEx to Interest Expense
5.01 1.88 -0.38 3.34 2.08 5.27 5.60 5.79 3.19 3.64
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.89 0.85 0.82 0.79 0.77 0.77 0.65 0.69 0.77 0.82
Accounts Receivable Turnover
10.32 10.07 9.81 9.80 9.20 8.85 7.76 8.38 8.47 8.25
Inventory Turnover
6.99 6.54 6.64 6.93 7.20 7.21 5.91 6.46 6.85 6.81
Fixed Asset Turnover
3.66 3.61 3.53 3.64 3.70 3.76 3.12 3.66 4.16 3.96
Accounts Payable Turnover
5.15 4.15 3.81 3.76 3.82 3.72 3.14 3.44 3.62 3.61
Days Sales Outstanding (DSO)
35.35 36.25 37.20 37.24 39.66 41.26 47.01 43.57 43.11 44.23
Days Inventory Outstanding (DIO)
52.19 55.84 54.94 52.70 50.72 50.66 61.73 56.49 53.31 53.57
Days Payable Outstanding (DPO)
70.88 88.01 95.85 97.16 95.53 98.04 116.10 106.11 100.80 101.22
Cash Conversion Cycle (CCC)
16.66 4.08 -3.71 -7.23 -5.14 -6.13 -7.35 -6.05 -4.37 -3.42
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
9,176 8,975 10,099 11,318 10,435 10,285 10,616 9,023 8,784 8,832
Invested Capital Turnover
1.43 1.43 1.35 1.27 1.25 1.33 1.12 1.29 1.47 1.45
Increase / (Decrease) in Invested Capital
-601 -201 1,124 1,219 -883 -150 331 -1,593 -239 48
Enterprise Value (EV)
24,682 25,356 25,042 23,687 26,162 24,526 25,399 27,436 24,001 32,844
Market Capitalization
17,634 18,291 17,121 14,970 18,474 17,353 18,503 21,169 18,392 27,787
Book Value per Share
$6.00 $5.44 $6.30 $7.50 $8.05 $9.05 $10.91 $11.55 $9.27 $10.95
Tangible Book Value per Share
($14.41) ($16.03) ($17.27) ($19.62) ($16.68) ($15.06) ($13.07) ($10.78) ($11.43) ($8.67)
Total Capital
9,883 9,693 10,809 12,052 11,236 11,111 11,326 10,939 9,242 9,625
Total Debt
7,745 7,767 8,615 8,893 7,922 7,475 7,111 6,564 5,873 5,743
Total Long-Term Debt
5,275 6,698 7,836 8,207 7,195 6,746 6,262 5,317 5,089 4,998
Net Debt
7,038 7,049 7,905 8,159 7,121 6,649 6,401 5,833 5,415 4,950
Capital Expenditures (CapEx)
553 507 501 578 586 505 553 488 677 628
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-284 -745 -988 -1,007 -1,017 -1,462 -1,358 -1,215 -1,220 -855
Debt-free Net Working Capital (DFNWC)
-33 -465 -707 -686 -620 -1,027 -1,072 -916 -946 -161
Net Working Capital (NWC)
-2,503 -1,534 -1,486 -1,372 -1,347 -1,756 -1,921 -2,163 -1,730 -906
Net Nonoperating Expense (NNE)
253 410 -210 130 79 142 -441 9.34 168 186
Net Nonoperating Obligations (NNO)
7,038 7,049 7,905 8,159 7,121 6,649 6,401 4,648 5,415 4,950
Total Depreciation and Amortization (D&A)
534 517 481 516 484 479 467 478 419 367
Debt-free, Cash-free Net Working Capital to Revenue
-2.10% -5.75% -7.69% -7.43% -7.49% -10.62% -11.56% -9.60% -9.30% -6.71%
Debt-free Net Working Capital to Revenue
-0.24% -3.59% -5.50% -5.06% -4.57% -7.46% -9.13% -7.24% -7.21% -1.26%
Net Working Capital to Revenue
-18.51% -11.83% -11.56% -10.13% -9.92% -12.75% -16.35% -17.09% -13.18% -7.11%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.74 $1.98 $3.65 $3.85 $2.81 $3.65 $4.36 $2.81 $2.78 $7.84
Adjusted Weighted Average Basic Shares Outstanding
350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Adjusted Diluted Earnings per Share
$1.72 $1.96 $3.62 $3.83 $2.80 $3.63 $4.33 $2.79 $2.76 $7.76
Adjusted Weighted Average Diluted Shares Outstanding
350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $2.81 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
350.26M 351.14M 345.75M 343.89M 342.05M 343.95M 341.67M 341.83M 340.68M 345.22M
Normalized Net Operating Profit after Tax (NOPAT)
867 1,110 1,044 1,474 1,056 1,406 1,047 969 1,132 1,529
Normalized NOPAT Margin
6.41% 8.56% 8.12% 10.88% 7.78% 10.21% 8.91% 7.66% 8.62% 11.99%
Pre Tax Income Margin
5.72% 7.20% 12.89% 9.81% 9.61% 11.63% 12.36% 7.13% 7.93% 12.97%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
4.41 3.30 7.47 5.63 5.60 6.70 8.08 5.49 4.43 6.32
NOPAT to Interest Expense
3.82 2.73 4.08 5.13 3.72 5.00 5.11 4.82 3.73 4.92
EBIT Less CapEx to Interest Expense
1.97 2.05 5.52 3.62 3.53 4.90 5.39 3.06 2.20 4.30
NOPAT Less CapEx to Interest Expense
1.38 1.48 2.12 3.12 1.66 3.21 2.41 2.39 1.50 2.90
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
114.01% 102.29% 58.69% 56.70% 78.71% 61.87% 52.96% 83.02% 82.99% 57.78%
Augmented Payout Ratio
233.06% 163.14% 99.84% 80.51% 101.23% 61.87% 69.09% 114.27% 100.62% 57.78%

Quarterly Metrics and Ratios for Kellanova

This table displays calculated financial ratios and metrics derived from Kellanova's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
8.95% 18.76% -8.99% -13.28% -17.51% 171.05% -4.25% -4.74% -0.68% -1.58%
EBITDA Growth
-4.63% -229.00% -32.54% -6.57% -13.27% 202.33% 8.98% 11.89% 22.63% 134.85%
EBIT Growth
-5.59% -587.34% -38.58% -6.32% -16.59% 147.53% 20.11% 18.20% 35.51% 187.43%
NOPAT Growth
-13.21% -88.54% -32.98% 3.54% 0.18% 400.85% 10.13% 16.44% 40.35% 126.77%
Net Income Growth
2.30% -123.89% -28.77% 9.51% -13.78% 135.29% -10.26% -3.64% 36.43% 902.78%
EPS Growth
1.12% -55.28% -30.08% 116.84% 73.33% -168.80% -9.30% -2.91% 34.62% 267.44%
Operating Cash Flow Growth
-18.12% -15.29% -15.60% -23.01% 101.60% -47.98% 31.88% 2.17% -26.85% 90.61%
Free Cash Flow Firm Growth
280.03% 520.47% 458.64% 341.93% 145.78% -72.14% 205.84% 118.78% 78.15% -11.58%
Invested Capital Growth
-0.51% -15.01% -3.28% -4.56% -5.32% -2.65% -15.48% -13.72% -11.12% 0.55%
Revenue Q/Q Growth
2.12% -70.32% 185.40% 0.27% -2.86% -2.49% 0.82% -0.25% 1.28% -3.37%
EBITDA Q/Q Growth
-9.93% -148.22% 285.66% 15.87% -16.40% -43.10% 97.73% 18.97% -8.37% 8.96%
EBIT Q/Q Growth
-11.16% -191.23% 194.29% 22.59% -20.90% -48.01% 138.25% 20.64% -9.32% 10.27%
NOPAT Q/Q Growth
-7.04% -120.98% 539.75% 20.70% -10.06% -36.98% 60.97% 27.62% 8.41% 1.82%
Net Income Q/Q Growth
-4.29% -132.69% 396.08% 18.21% -24.65% -86.62% 652.78% 26.94% 6.69% -1.63%
EPS Q/Q Growth
-5.26% 177.78% -65.60% 139.53% -24.27% -210.26% 145.35% 156.41% 5.00% 37.14%
Operating Cash Flow Q/Q Growth
-21.55% 25.60% -41.40% 33.33% 105.43% -67.59% 48.57% 3.30% 47.07% -15.55%
Free Cash Flow Firm Q/Q Growth
88.27% 336.22% -58.84% 30.75% 4.70% -50.55% 351.82% -6.47% -14.74% -75.46%
Invested Capital Q/Q Growth
-1.81% -15.08% 16.31% -1.59% -2.59% -12.68% 0.98% 0.46% 0.34% -1.22%
Profitability Metrics
- - - - - - - - - -
Gross Margin
29.22% 30.40% 29.44% 32.65% 34.10% 34.50% 32.22% 36.37% 36.37% 37.68%
EBITDA Margin
13.56% -22.03% 14.33% 16.56% 14.26% 8.32% 16.31% 19.45% 17.60% 19.85%
Operating Margin
9.33% -7.60% 10.35% 12.44% 12.72% 10.33% 12.28% 15.44% 14.10% 17.00%
EBIT Margin
10.69% -32.88% 10.86% 13.28% 10.81% 5.77% 13.63% 16.48% 14.75% 16.84%
Profit (Net Income) Margin
7.91% -8.71% 9.04% 10.65% 8.26% 1.13% 8.47% 10.78% 11.35% 11.56%
Tax Burden Percent
81.46% 23.34% 103.07% 95.97% 97.11% 36.73% 76.77% 77.65% 91.29% 79.17%
Interest Burden Percent
90.76% 113.51% 80.72% 83.60% 78.69% 53.55% 80.96% 84.22% 84.28% 86.69%
Effective Tax Rate
19.32% 0.00% 20.82% 20.70% 28.16% 42.86% 23.23% 21.90% 8.46% 19.96%
Return on Invested Capital (ROIC)
8.81% -6.86% 9.47% 11.02% 9.82% 8.70% 12.64% 16.08% 17.39% 19.69%
ROIC Less NNEP Spread (ROIC-NNEP)
9.05% -7.57% 9.91% 11.45% 9.34% 5.69% 12.11% 15.37% 16.47% 18.46%
Return on Net Nonoperating Assets (RNNOA)
12.99% -9.74% 14.20% 16.13% 12.09% 7.40% 18.12% 23.29% 22.48% 26.38%
Return on Equity (ROE)
21.79% -16.60% 23.67% 27.15% 21.91% 16.10% 30.76% 39.37% 39.88% 46.08%
Cash Return on Invested Capital (CROIC)
9.85% 26.09% 11.18% 12.76% 13.63% 15.39% 28.75% 27.33% 25.90% 16.81%
Operating Return on Assets (OROA)
7.13% -22.69% 7.19% 8.47% 6.38% 4.44% 10.42% 12.65% 10.96% 13.74%
Return on Assets (ROA)
5.27% -6.01% 5.98% 6.79% 4.87% 0.87% 6.48% 8.27% 8.43% 9.43%
Return on Common Equity (ROCE)
19.35% -14.80% 21.17% 24.89% 20.22% 14.80% 28.57% 37.44% 38.16% 44.16%
Return on Equity Simple (ROE_SIMPLE)
34.77% 0.00% 20.68% 21.92% 20.46% 0.00% 29.60% 27.82% 27.89% 0.00%
Net Operating Profit after Tax (NOPAT)
297 -62 274 331 297 187 302 385 417 425
NOPAT Margin
7.52% -5.32% 8.20% 9.87% 9.14% 5.91% 9.43% 12.06% 12.91% 13.61%
Net Nonoperating Expense Percent (NNEP)
-0.24% 0.72% -0.45% -0.43% 0.49% 3.01% 0.53% 0.71% 0.92% 1.24%
Return On Investment Capital (ROIC_SIMPLE)
2.60% -0.57% 2.43% 3.02% 2.62% 2.03% 3.28% 4.14% 4.34% 4.42%
Cost of Revenue to Revenue
70.78% 69.60% 70.56% 67.35% 65.90% 65.50% 67.78% 63.63% 63.63% 62.32%
SG&A Expenses to Revenue
19.89% 38.00% 19.09% 20.20% 21.38% 24.17% 19.94% 20.93% 22.27% 20.68%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.89% 38.00% 19.09% 20.20% 21.38% 24.17% 19.94% 20.93% 22.27% 20.68%
Earnings before Interest and Taxes (EBIT)
422 -385 363 445 352 183 436 526 477 526
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
535 -258 479 555 464 264 522 621 569 620
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.78 5.37 4.96 5.16 4.52 5.79 6.04 5.84 7.47 7.36
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.64 1.67 1.63 1.73 1.64 1.40 1.47 1.51 2.13 2.18
Price to Earnings (P/E)
13.79 22.10 24.11 23.81 22.29 19.34 20.69 21.24 27.13 20.89
Dividend Yield
3.87% 3.77% 4.00% 3.95% 4.45% 4.36% 4.16% 4.04% 2.82% 2.80%
Earnings Yield
7.25% 4.53% 4.15% 4.20% 4.49% 5.17% 4.83% 4.71% 3.69% 4.79%
Enterprise Value to Invested Capital (EV/IC)
2.52 3.04 2.53 2.60 2.41 2.73 2.79 2.80 3.64 3.72
Enterprise Value to Revenue (EV/Rev)
2.15 2.17 2.15 2.27 2.18 1.83 1.91 1.94 2.54 2.58
Enterprise Value to EBITDA (EV/EBITDA)
13.14 17.35 19.66 20.47 19.56 13.62 13.71 13.32 16.48 14.08
Enterprise Value to EBIT (EV/EBIT)
17.10 24.87 30.34 31.76 31.30 17.87 17.48 16.64 20.07 16.71
Enterprise Value to NOPAT (EV/NOPAT)
26.93 28.30 31.73 31.35 28.72 21.21 21.37 20.55 24.27 21.48
Enterprise Value to Operating Cash Flow (EV/OCF)
15.44 16.62 16.59 18.01 12.96 14.59 14.28 14.31 21.17 18.66
Enterprise Value to Free Cash Flow (EV/FCFF)
25.54 10.71 22.26 19.89 17.21 17.51 8.89 9.48 13.23 22.18
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.41 1.50 1.52 1.60 1.65 1.74 1.81 1.71 1.56 1.48
Long-Term Debt to Equity
1.20 1.22 1.29 1.20 1.29 1.51 1.34 1.46 1.34 1.29
Financial Leverage
1.44 1.29 1.43 1.41 1.29 1.30 1.50 1.52 1.36 1.43
Leverage Ratio
4.28 4.27 4.24 4.22 4.18 4.41 4.38 4.37 4.29 4.31
Compound Leverage Factor
3.88 4.85 3.43 3.53 3.29 2.36 3.54 3.68 3.61 3.74
Debt to Total Capital
58.53% 60.01% 60.28% 61.48% 62.33% 63.55% 64.42% 63.11% 60.90% 59.67%
Short-Term Debt to Total Capital
8.67% 11.40% 9.21% 15.15% 13.62% 8.48% 16.71% 9.21% 8.34% 7.74%
Long-Term Debt to Total Capital
49.86% 48.61% 51.07% 46.34% 48.71% 55.06% 47.71% 53.90% 52.55% 51.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.98% 3.97% 3.79% 2.34% 2.11% 2.10% 1.37% 1.29% 1.12% 1.11%
Common Equity to Total Capital
37.49% 36.03% 35.93% 36.18% 35.57% 34.35% 34.22% 35.60% 37.98% 39.22%
Debt to EBITDA
3.28 4.15 5.03 5.14 5.71 3.33 3.29 3.13 2.96 2.46
Net Debt to EBITDA
2.89 3.69 4.46 4.66 4.66 3.07 3.10 2.93 2.62 2.12
Long-Term Debt to EBITDA
2.79 3.36 4.27 3.87 4.46 2.89 2.43 2.68 2.56 2.14
Debt to NOPAT
6.72 6.77 8.12 7.87 8.38 5.19 5.12 4.84 4.36 3.76
Net Debt to NOPAT
5.92 6.02 7.19 7.13 6.85 4.79 4.83 4.52 3.86 3.24
Long-Term Debt to NOPAT
5.72 5.49 6.88 5.93 6.55 4.50 3.79 4.13 3.77 3.27
Altman Z-Score
2.19 2.07 2.17 2.20 2.03 2.44 2.54 2.65 3.01 3.12
Noncontrolling Interest Sharing Ratio
11.20% 10.81% 10.57% 8.34% 7.70% 8.11% 7.13% 4.92% 4.32% 4.15%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.74 0.66 0.72 0.66 0.76 0.66 0.62 0.73 0.77 0.81
Quick Ratio
0.39 0.29 0.36 0.35 0.46 0.36 0.35 0.40 0.46 0.48
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
351 1,531 630 824 862 426 1,927 1,802 1,536 377
Operating Cash Flow to CapEx
451.81% 341.30% 135.96% 270.59% 452.69% 143.27% 234.84% 264.79% 386.71% 248.40%
Free Cash Flow to Firm to Interest Expense
9.00 29.44 9.00 11.28 11.50 5.02 23.21 21.71 20.49 5.39
Operating Cash Flow to Interest Expense
9.62 9.06 3.94 5.04 10.08 2.88 4.39 4.53 7.37 6.67
Operating Cash Flow Less CapEx to Interest Expense
7.49 6.40 1.04 3.18 7.85 0.87 2.52 2.82 5.47 3.99
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.67 0.69 0.66 0.64 0.59 0.77 0.76 0.77 0.74 0.82
Accounts Receivable Turnover
6.80 8.38 7.03 6.19 5.76 8.47 7.45 7.15 7.16 8.25
Inventory Turnover
5.72 6.46 5.17 4.86 4.57 6.85 5.75 5.83 5.85 6.81
Fixed Asset Turnover
3.41 3.66 3.26 3.18 3.04 4.16 3.77 3.72 3.67 3.96
Accounts Payable Turnover
3.24 3.44 3.10 2.90 2.68 3.62 3.39 3.32 3.23 3.61
Days Sales Outstanding (DSO)
53.65 43.57 51.94 58.94 63.37 43.11 49.01 51.02 50.98 44.23
Days Inventory Outstanding (DIO)
63.82 56.49 70.59 75.10 79.84 53.31 63.53 62.63 62.42 53.57
Days Payable Outstanding (DPO)
112.57 106.11 117.75 125.97 136.36 100.80 107.79 109.99 112.90 101.22
Cash Conversion Cycle (CCC)
4.90 -6.05 4.77 8.07 6.85 -4.37 4.75 3.66 0.49 -3.42
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
10,625 9,023 10,495 10,328 10,060 8,784 8,870 8,911 8,941 8,832
Invested Capital Turnover
1.17 1.29 1.15 1.12 1.08 1.47 1.34 1.33 1.35 1.45
Increase / (Decrease) in Invested Capital
-54 -1,593 -356 -493 -565 -239 -1,625 -1,417 -1,119 48
Enterprise Value (EV)
26,802 27,436 26,548 26,837 24,254 24,001 24,754 24,913 32,558 32,844
Market Capitalization
20,460 21,169 20,105 20,474 18,232 18,392 19,036 19,309 27,267 27,787
Book Value per Share
$12.59 $11.55 $11.85 $11.57 $11.80 $9.27 $9.24 $9.67 $10.66 $10.95
Tangible Book Value per Share
($10.91) ($10.78) ($11.51) ($10.63) ($10.29) ($11.43) ($10.98) ($10.35) ($9.33) ($8.67)
Total Capital
11,425 10,939 11,276 10,959 11,353 9,242 9,212 9,290 9,611 9,625
Total Debt
6,687 6,564 6,797 6,738 7,076 5,873 5,934 5,863 5,853 5,743
Total Long-Term Debt
5,697 5,317 5,759 5,078 5,530 5,089 4,395 5,007 5,051 4,998
Net Debt
5,887 5,833 6,016 6,107 5,783 5,415 5,592 5,484 5,183 4,950
Capital Expenditures (CapEx)
83 138 203 136 167 171 155 142 143 188
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-972 -1,215 -986 -836 -1,091 -1,220 -778 -720 -887 -855
Debt-free Net Working Capital (DFNWC)
-599 -916 -639 -528 8.00 -946 -536 -448 -318 -161
Net Working Capital (NWC)
-1,589 -2,163 -1,677 -2,188 -1,538 -1,730 -2,075 -1,304 -1,120 -906
Net Nonoperating Expense (NNE)
-15 40 -28 -26 28 151 31 41 50 64
Net Nonoperating Obligations (NNO)
5,887 4,648 6,016 6,107 5,783 5,415 5,592 5,484 5,183 4,950
Total Depreciation and Amortization (D&A)
113 127 116 110 112 81 86 95 92 94
Debt-free, Cash-free Net Working Capital to Revenue
-7.80% -9.60% -8.00% -7.08% -9.81% -9.30% -5.99% -5.62% -6.93% -6.71%
Debt-free Net Working Capital to Revenue
-4.80% -7.24% -5.19% -4.47% 0.07% -7.21% -4.13% -3.49% -2.48% -1.26%
Net Working Capital to Revenue
-12.74% -17.09% -13.61% -18.53% -13.83% -13.18% -15.99% -10.17% -8.75% -7.11%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.91 $2.51 $0.87 $1.04 $0.79 ($1.75) $0.78 $2.02 $2.14 $2.90
Adjusted Weighted Average Basic Shares Outstanding
341M 341.83M 342M 343M 342M 340.68M 341M 342M 343M 345.22M
Adjusted Diluted Earnings per Share
$0.90 $2.50 $0.86 $1.03 $0.78 ($1.72) $0.78 $2.00 $2.10 $2.88
Adjusted Weighted Average Diluted Shares Outstanding
344M 341.83M 345M 345M 345M 340.68M 344M 345M 347M 345.22M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
341.28M 341.83M 342.76M 342.35M 342.52M 340.68M 341.88M 342.29M 344.70M 345.22M
Normalized Net Operating Profit after Tax (NOPAT)
297 -62 274 331 297 187 302 385 417 425
Normalized NOPAT Margin
7.52% -5.32% 8.20% 9.87% 9.14% 5.91% 9.43% 12.06% 12.91% 13.61%
Pre Tax Income Margin
9.71% -37.32% 8.77% 11.10% 8.51% 3.09% 11.03% 13.88% 12.43% 14.60%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
10.82 -7.40 5.19 6.10 4.69 2.15 5.25 6.34 6.36 7.51
NOPAT to Interest Expense
7.61 -1.20 3.91 4.53 3.97 2.21 3.64 4.64 5.57 6.07
EBIT Less CapEx to Interest Expense
8.69 -10.06 2.29 4.23 2.47 0.14 3.39 4.63 4.45 4.83
NOPAT Less CapEx to Interest Expense
5.48 -3.85 1.01 2.67 1.74 0.19 1.77 2.93 3.66 3.39
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
53.32% 83.02% 95.70% 92.87% 98.18% 82.99% 84.57% 84.67% 75.64% 57.78%
Augmented Payout Ratio
73.47% 114.27% 95.70% 99.77% 105.45% 100.62% 102.79% 96.63% 86.44% 57.78%

Frequently Asked Questions About Kellanova's Financials

When does Kellanova's fiscal year end?

According to the most recent income statement we have on file, Kellanova's financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has Kellanova's net income changed over the last 9 years?

Kellanova's net income appears to be on an upward trend, with a most recent value of $1.34 billion in 2024, rising from $614 million in 2015. The previous period was $964 million in 2023.

What is Kellanova's operating income?
Kellanova's total operating income in 2024 was $1.87 billion, based on the following breakdown:
  • Total Gross Profit: $4.55 billion
  • Total Operating Expenses: $2.67 billion
How has Kellanova revenue changed over the last 9 years?

Over the last 9 years, Kellanova's total revenue changed from $13.53 billion in 2015 to $12.75 billion in 2024, a change of -5.7%.

How much debt does Kellanova have?

Kellanova's total liabilities were at $11.75 billion at the end of 2024, a 4.1% decrease from 2023, and a 10.4% decrease since 2015.

How much cash does Kellanova have?

In the past 9 years, Kellanova's cash and equivalents has ranged from $251 million in 2015 to $694 million in 2024, and is currently $694 million as of their latest financial filing in 2024.

How has Kellanova's book value per share changed over the last 9 years?

Over the last 9 years, Kellanova's book value per share changed from 6.00 in 2015 to 10.95 in 2024, a change of 82.4%.

Remove Ads


This page (NYSE:K) was last updated on 4/14/2025 by MarketBeat.com Staff
From Our Partners